Microorganism |
|
|
|
Antimicrobial |
|
|
Reference |
Streptococci (serogroup B + β-hemolytic) |
0.03 |
0.06 |
≤0.016 - 0.12 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
472 |
Streptococci (serogroup B + β-hemolytic) |
0.03 |
0.06 |
≤0.016 - 0.25 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin) |
412 |
Streptococci (serogroup B + β-hemolytic) |
0.06 |
0.06 |
≤0.008 - 0.5 |
Ceftriaxone (Rocephin) |
412 |
Streptococci (serogroup B + β-hemolytic) |
≤0.06 |
≤0.06 |
≤0.06 - >8 |
Clindamycin (Cleocin) |
412 |
Streptococci (serogroup B + β-hemolytic) |
≤0.06 |
≤0.06 |
≤0.06 - >8 |
Clindamycin (Cleocin) |
472 |
Streptococci (serogroup B + β-hemolytic) |
0.06 |
2 |
≤0.06 - >8 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
472 |
Streptococci (serogroup B + β-hemolytic) |
0.06 |
2 |
≤0.06 - >32 |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
412 |
Streptococci (serogroup B + β-hemolytic) |
≤0.12 |
≤0.12 |
≤0.12 - 0.25 |
Tigecycline (GAR-936, Tigacyl) |
472 |
Streptococci (serogroup B + β-hemolytic) |
≤0.12 |
≤0.12 |
≤0.12 - 0.5 |
Cefepime (Maxipime) |
412 |
Streptococci (serogroup B + β-hemolytic) |
≤0.25 |
≤0.25 |
≤0.25 - 0.5 |
Ceftriaxone (Rocephin) |
472 |
Streptococci (serogroup B + β-hemolytic) |
0.5 |
0.5 |
0.25 - 1 |
Vancomycin (Vancocyn, Lyphocin) |
472 |
Streptococci (serogroup B + β-hemolytic) |
0.5 |
1 |
0.06 - >4 |
Levofloxacin (Levaquin, Quixin) |
472 |
Streptococci (serogroup B + β-hemolytic) |
≤2 |
≤2 |
≤2 - 4 |
Amoxicillin-clavulanate |
412 |
Streptococci (serogroup B + β-hemolytic) |
>8 |
>8 |
≤2 - >8 |
Tetracycline (Sumycin, Achromycin V, Steclin) |
472 |